BIOREGENX, INC. financial data

Symbol
BRGX on OTC
Location
Chattanooga, TN
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 7% % -47%
Quick Ratio 3% % -42%
Debt-to-equity -123% % -461%
Return On Equity 532% %
Return On Assets -2288% % -6275%
Operating Margin -965% % -430%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 961,992,601 shares 0.57%
Common Stock, Shares, Outstanding 961,992,601 shares 0.57%
Entity Public Float $5,587,115 USD 32%
Common Stock, Value, Issued $961,993 USD 0.57%
Weighted Average Number of Shares Outstanding, Basic 960,873,144 shares 0.45%
Weighted Average Number of Shares Outstanding, Diluted 960,873,144 shares 0.45%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $1,929,361 USD -25%
Cost of Revenue $421,740 USD -50%
Research and Development Expense $33,036 USD -168%
Operating Income (Loss) $18,625,148 USD -300%
Nonoperating Income (Expense) $522,358 USD -258%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $1,750,786 USD -546%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $18,926,335 USD -285%
Earnings Per Share, Basic 0 USD/shares -100%
Earnings Per Share, Diluted 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $83,625 USD -27%
Accounts Receivable, after Allowance for Credit Loss, Current $62,610 USD 222%
Inventory, Net $109,378 USD -31%
Other Assets, Current $49,057 USD -33%
Assets, Current $273,156 USD -26%
Property, Plant and Equipment, Net $169,608 USD -20%
Intangible Assets, Net (Excluding Goodwill) $17,061,726 USD
Goodwill $7,105,522 USD
Other Assets, Noncurrent $0 USD -100%
Assets $1,167,764 USD -93%
Accounts Payable, Current $459,652 USD -6.7%
Employee-related Liabilities, Current $48,000 USD
Accrued Liabilities, Current $380,599 USD -11%
Liabilities, Current $3,933,831 USD 12%
Liabilities $4,814,900 USD 27%
Accumulated Other Comprehensive Income (Loss), Net of Tax $7,222 USD -1269%
Retained Earnings (Accumulated Deficit) $36,097,759 USD -110%
Stockholders' Equity Attributable to Parent $3,647,136 USD -127%
Liabilities and Equity $1,167,764 USD -93%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $37,695 USD
Net Cash Provided by (Used in) Financing Activities $10,415 USD -104%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 1,500,000,000 shares 0%
Common Stock, Shares, Issued 961,992,601 shares 0.57%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $25,221 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $46,947 USD -33%
Interest Paid, Excluding Capitalized Interest, Operating Activities $23,193 USD 693%
Deferred Tax Assets, Valuation Allowance $3,317,700 USD 128%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $18,924,391 USD -285%
Deferred Tax Assets, Operating Loss Carryforwards $1,374,000 USD 94%
Additional Paid in Capital $31,488,626 USD 5.7%
Amortization of Intangible Assets $562,089 USD
Depreciation, Depletion and Amortization $520,547 USD 937%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Interest Expense $72,106 USD 6.7%